Takero Shindo

J-GLOBAL         Last updated: Jun 17, 2019 at 20:44
 
Avatar
Name
Takero Shindo
Affiliation
Kyoto University
ORCID ID
0000-0002-2085-6151

Published Papers

 
Trametinib attenuates delayed rejection and preserves thymic function in rat lung transplantation.
Takahagi A, Shindo T, Chen-Yoshikawa TF, Yoshizawa A, Gochi F, Miyamoto E, Saito M, Tanaka S, Motoyama H, Aoyama A, Takaori-Kondo A, Date H.
Am J Respir Cell Mol Biol      2019   [Refereed]
Allelic polymorphism of KIRs in chronic myeloid leukemia
Shindo T, Ureshino H, Kojima H, Tanaka H, Kimura S.
MHC   25(3) 187-195   Dec 2018   [Refereed][Invited]
Epstein-Barr virus-related diffuse large B cell lymphoma in mogamulizumab-treated adult T cell leukemia with incomplete T cell reconstitution.
Kamachi K, Shindo T*, Miyahara M, Kitaura K, Akashi M, Shin-I T, Suzuki R, Ohshima K, Kimura S.
Int J Hematol   109(2) 221-227   Feb 2019   [Refereed]
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/kymphoma.
Ureshino H, Kusaba K, Kidoguchi K, Sano H, Nishioka A, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Kimura S.
Ann Hematol   98(2) 465-471   Feb 2019   [Refereed]
Monitoring of citrulline and diamine oxidase levels as biomarkers for intestinal mucositis during early-phase of hematopoietic cell transplantation.
Fukushima N, Tomiyasu S, Uji Y, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Ichinohe T, Kimura S.
Blood Cell Ther      Aug 2018   [Refereed]
Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML.
Ureshino H, Shindo T*, Kojima H, Kusunoki Y, Miyazaki Y, Tanaka H, Saji H, Kawaguchi A, Kimura S.
Cancer Immunol Res   6(6) 745-755   Jun 2018   [Refereed]
Kitamura H, Kubota Y, Yamaguchi K, Kamachi K, Nishioka A, Yokoo M, Shindo T, Ando T, Kojima K, Kimura S.
Intern Med   57(6) 855-860   Jun 2018   [Refereed]
Outcome of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.
Fuji S, Utsunomiya A, Inoue Y, Miyagi T, Owatari S, Sawayama Y, Moriuchi Y, Choi I, Shindo T, Yoshida S, Yamasaki S, Yamaguchi T, Fukuda T.
Haematologica   103(5) e211-e214   May 2018   [Refereed]
Fujii S, Miura Y, Fujishiro A, Shindo T, Shimazu Y, Hirai H, Tahara H, Takaori-Kondo A, Ichinohe T, Maekawa T.
Stem Cells   36(3) 434-445   Mar 2018   [Refereed]
Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia.
Shindo T*, Kitaura K, Ureshino H, Kamachi K, Miyahara M, Doi K, Watanabe T, Sueoka E, Shin-I T, Suzuki R, Kimura S.
Oncoimmunol   7(3) e1405204   Mar 2018   [Refereed]
Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Nishioka A, Itamura H, Shindo T, Kubota Y, Kojima K, Kimura S.
Hematol Oncol   36(1) 324-327   Jan 2018   [Refereed]
Kai K, Koga F, Araki N, Shindo T, Eguchi Y, Toda S, Aishima S.
Pathol Int   67(8) 431-433   Aug 2017   [Refereed]
Itamura H, Kubota Y, Shindo T, Ando T, Kojima K, Kimura S
Clin Lymph Myeloma Leuk   17(6) 370-374   Jun 2017   [Refereed]
Akutagawa T, Shindo T*, Yamanouchi K, Hayakawa M, Ureshino H, Tsuruoka N, Sakata Y, Shimoda R, Noguchi R, Furukawa K, Morita S, Iwakiri R, Kimura S, Matsumoto M, Fujimoto K
Intern Med   56(18) 2431-2433   Sep 2017   [Refereed]
Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S.
Int J Hematol   105(5) 692-696   May 2017   [Refereed]
Ureshino H, Shindo T, Tanaka H, Kimura S.
Rinsho Ketsueki   58(4) 381-388   Apr 2017   [Refereed][Invited]
Ureshino H, Nishioka A, Kojima K, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.
Intern Med   55(18) 2703-2706   Sep 2016   [Refereed]
Ureshino H, Nishioka A, Kojima K, Suzuki M, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.
Intern Med   55(15) 2061-2064   Aug 2016   [Refereed]
The MEK inhibitor trametinib separates murine Graft-versus-Host Disease from Graft-versus-Tumor Effects.
Itamura H, Shindo T*, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S
JCI Insight   1(10) e86331   Jul 2016   [Refereed]
Kitamura H, Shindo T*, Yakushiji Y, Yoshihara M, Eriguchi M, Kubota Y, Noguchi T, Kimura S.
JAMA Neurol   73(4) 474-475   Apr 2016   [Refereed]

Conference Activities & Talks

 
Phosphorylation of ERK1/2 in CD4+ T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation
Takero Shindo, Hidekazu Itamura, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura
The 80th annual meeting of the Japanese Society of Hematology   12 Oct 2018   
TCR Repertoire, Effector Regulatory T-cells and KIR Genotyping Uncover Immunological Dynamics in Mogamulizumab-treated ATL
Takero Shindo, Yasushi Kusunoki, Kazutaka Kitaura, Hiroyoshi Nishikawa, Nobukazu Watanabe, Hiroshi Ureshino, Masaharu Miyahara, Tatsuro Watanabe, Eizaburo Sueoka, Luis J Espinoza, Akiyoshi Takami, Tatsuo Ichinohe, Ryuji Suzuki, Hidenori Tanaka, Hiroh Saji, Shinya Kimura
International Conference of Human Retrovirology HTLV and related viruses   2017   
The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT and antiviral immunity. [Invited]
Takero Shindo
The 7th Japanese Society of Hematology (JSH) International Symposium   14 May 2016   
The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT effects.
Itamura H, Shindo T, Tawara I, Kariya R, Okada S, Komanduri KV.
Biol Blood Marrow Transplant   Feb 2015   
Trametinib selectively inhibits alloreactivity while sparing virus-specific T cells.
Wieder ED, Kolonias D, Benjamin CL, Shindo T, Kim TK, Levy RB, Komanduri KV.
Biol Blood Marrow Transplant   Feb 2014